EUVIMEDPoznaj EUVIMED
Multizentrische StudieOpen access · CC BY-NC 4.0

Epidemiology, Treatment, and Outcomes of Gram‐Negative Bacteremia in a Multicenter Cohort of Solid Organ Transplant Recipients

Sarah B Doernberg iD, Emily L Heil iD, Suiyini Fiawoo, Jae Hyoung Lee, Sara E Cosgrove, David M Dobrzynski iD, Yihan Li, Ryan K Shields iD, Emily S Spivak, Erica J Stohs iD, Pranita D Tamma, Erin K McCreary iD

Clinical Transplantation · 2025-04 · 39 (4)

DOI: 10.1111/ctr.70160 ↗

At a glance

Multizentrische Studie in Clinical Transplantation, published online on 2025-04-22. Written by Sarah B Doernberg and 11 co-authors. Institution: Division of Infectious Diseases, Department of Medicine, University of California, San Francisco, California, USA. Major MEDLINE topics: Organ Transplantation, Bacteremia, Gram-Negative Bacterial Infections, Transplant Recipients. Cited 5 times so far (Crossref); 22 references. The full text is freely available (open access, CC BY-NC 4.0).

AbstraktSubjectsDane bibliograficzneCiteRelated studies

Abstract (original language)

Introduction

Little is known about the epidemiology and management of gram‐negative bloodstream infections (GN‐BSIs) in patients after solid organ transplant (SOT). We describe epidemiology, treatment approaches, and outcomes in a subset of patients with SOT from a larger cohort with GN‐BSI.

Methods

This was a multicenter, retrospective cohort study that enrolled unique, consecutive adults with GN‐BSI hospitalized at any of 24 participating hospitals between January and December 2019.

Results

Of 4581 adults in the overall cohort, 298 (6.5%) were SOT recipients, including kidney (177, 59%), liver (67, 22%), heart (23, 8%), lung (12, 4%), and multiorgan (19, 6%) recipients. The most common organisms were Escherichia coli (45%), Klebsiella pneumoniae (20%), and Pseudomonas aeruginosa (15%). Twenty‐two percent of E. coli, Klebsiella spp ., or Proteus spp . isolates had extended‐spectrum beta‐lactamase phenotype. Sixty‐six (22%) subjects did not receive active empirical therapy within the first 48 h. Median treatment duration was 15 days (IQR 12–18 days). Transition to oral therapy occurred in 161 (54%) patients at a median of 4 days (IQR 3–7 days). Thirty‐one patients (10%) had recurrent bacteremia, and 10% of the cohort died within 90 days.

Discussion

In this large cohort of SOT patients with GN‐BSI, durations exceeded 14 days in most patients, while more than half transitioned to oral antibiotics. Approximately 1 in 5 did not receive active empirical antibiotics, highlighting the impact of drug resistance and the importance of access to rapid diagnostic tools in this patient population. Mortality aligned with published estimates from other studies.

Subjects

MeSH terms (MEDLINE)

Organ TransplantationBacteremiaGram-Negative Bacterial InfectionsTransplant RecipientsAnti-Bacterial AgentsGram-Negative BacteriaPostoperative ComplicationsHumansFemaleMaleRetrospective StudiesMiddle AgedPrognosisFollow-Up StudiesAdultRisk FactorsAged

Author keywords

bloodstream infectiongram‐negative bacillussolid organ transplantation

Substances

Anti-Bacterial Agents

Authors and institutions

  • Division of Infectious Diseases, Department of Medicine, University of California, San Francisco, California, USA.
  • Department of Practice, Sciences, and Health-Outcomes Research, University of Maryland School of Pharmacy, Baltimore, Maryland, USA.
  • Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Division of Infectious Diseases, University of Rochester Medical Center, Rochester, New York, USA.
  • Department of Pharmacy, NYU Langone Health, New York, New York, USA.

ORCID profiles: Sarah B Doernberg, Emily L Heil, David M Dobrzynski, Ryan K Shields, Erica J Stohs, Erin K McCreary

Cite

APA

Doernberg, S. B., Heil, E. L., Fiawoo, S., Lee, J. H., Cosgrove, S. E., Dobrzynski, D. M., Li, Y., Shields, R. K., Spivak, E. S., Stohs, E. J., Tamma, P. D., & McCreary, E. K. (2025). Epidemiology, Treatment, and Outcomes of Gram‐Negative Bacteremia in a Multicenter Cohort of Solid Organ Transplant Recipients. Clinical Transplantation, 39(4). https://doi.org/10.1111/ctr.70160

Vancouver

Doernberg SB, Heil EL, Fiawoo S, Lee JH, Cosgrove SE, Dobrzynski DM, et al. Epidemiology, Treatment, and Outcomes of Gram‐Negative Bacteremia in a Multicenter Cohort of Solid Organ Transplant Recipients. Clinical Transplantation. 2025;39(4). doi:10.1111/ctr.70160

BibTeX
@article{Doernberg2025,
  author = {Doernberg, Sarah B and Heil, Emily L and Fiawoo, Suiyini and Lee, Jae Hyoung and Cosgrove, Sara E and Dobrzynski, David M and Li, Yihan and Shields, Ryan K and Spivak, Emily S and Stohs, Erica J and Tamma, Pranita D and McCreary, Erin K},
  title = {Epidemiology, Treatment, and Outcomes of Gram‐Negative Bacteremia in a Multicenter Cohort of Solid Organ Transplant Recipients},
  journal = {Clinical Transplantation},
  year = {2025},
  volume = {39},
  number = {4},
  doi = {10.1111/ctr.70160}
}
Start for free →